Publicaciones en colaboración con investigadores/as de University of Bordeaux (12)

2020

  1. Cannabinoid-induced motor dysfunction via autophagy inhibition

    Autophagy, Vol. 16, Núm. 12, pp. 2289-2291

  2. Glucose metabolism links astroglial mitochondria to cannabinoid effects

    Nature, Vol. 583, Núm. 7817, pp. 603-608

  3. Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination

    eLife, Vol. 9, pp. 1-24

2019

  1. Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons

    Neuropharmacology, Vol. 150, pp. 134-144

2018

  1. Pathway-specific control of striatal neuron vulnerability by corticostriatal cannabinoid CB 1 receptors

    Cerebral Cortex, Vol. 28, Núm. 1, pp. 307-322

2016

  1. Sustained Gq-protein signaling disrupts striatal circuits via JNK

    Journal of Neuroscience, Vol. 36, Núm. 41, pp. 10611-10624

2015

  1. Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington's disease

    Neuropharmacology, Vol. 89, pp. 368-374

  2. Early Social Enrichment Rescues Adult Behavioral and Brain Abnormalities in a Mouse Model of Fragile X Syndrome

    Neuropsychopharmacology, Vol. 40, pp. 1113-1122

2014

  1. A restricted population of CB1 cannabinoid receptors with neuroprotective activity

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 22, pp. 8257-8262

  2. The endocannabinoid system controls food intake via olfactory processes

    Nature Neuroscience, Vol. 17, Núm. 3, pp. 407-415

2013

  1. Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 12, pp. 4786-4791

2011

  1. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease

    Brain, Vol. 134, Núm. 1, pp. 119-136